Recombinant IL13 (Tralokinumab Biosimilar) 抗体
This anti-IL13 (Tralokinumab Biosimilar) antibody is a Mammalian Cells 单克隆 antibody detecting IL13 (Tralokinumab Biosimilar) in ELISA. Suitable for 人.
Quick Overview for Recombinant IL13 (Tralokinumab Biosimilar) 抗体 (ABIN7487857)
抗原
IL13 (Tralokinumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This IL13 (Tralokinumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Tralokinumab Biosimilar - Anti-IL13 mAb
-
产品特性
- Antibody Type: IgG4-lambda
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG4 lambda
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- IL13 (Tralokinumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
CAT-354
Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13, and is designed for the treatment of asthma and inflammatory diseases. -
CAS-编号
- 1044515-88-9
抗原
-
You are here:
